Central Corneal Thickness In Diabetic Vs. Non-Diabetic Eyes: A Cross Sectional Study
International Journal of Drug Delivery Technology · 18.05.2026 · 16 (28s)
DOI: 10.25258/ijddt.16.28s.82 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.05.2026. Verfasst von Kavya M und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Diabetes mellitus is known to cause microvascular and structural alterations in various ocular tissues, including the cornea. Central corneal thickness (cct) is an important parameter influencing intraocular pressure measurement and overall corneal health. However, the impact of diabetes, glycemic control, and disease duration on cct remains variable across populations, necessitating further evaluation.
Aim
To compare central corneal thickness in diabetic and non-diabetic individuals and to assess its association with diabetic retinopathy, glycemic status, and duration of diabetes. Materials and Methods: This hospital-based cross-sectional study included 146 participants, comprising 73 diabetic patients and 73 age-matched non-diabetic controls. All subjects underwent comprehensive ophthalmic evaluation. Cct was measured using anterior segment optical coherence tomography (as-oct). Diabetic patients were categorized based on the severity of diabetic retinopathy. Clinical variables including hba1c and duration of diabetes were recorded. Statistical analysis was performed using spss version 22, with p < 0.05 considered statistically significant.
Results
The mean cct was significantly higher in diabetic patients (567.14 ± 14.63 µm) compared to non-diabetic individuals (531.14 ± 5.00 µm; p < 0.001). A progressive increase in cct was observed with increasing severity of diabetic retinopathy (no dr: 562.0 µm, npdr: 566.9 µm, pdr: 577.0 µm), although this trend was not statistically significant (p = 0.082). Univariate analysis showed that diabetes (or: 5.92), hba1c ≥7% (or: 4.11), and duration of diabetes ≥5 years (or: 2.95) were significantly associated with increased cct. Multivariate analysis confirmed diabetes (aor: 4.82), elevated hba1c (aor: 3.26), and longer duration (aor: 2.11) as independent predictors.
Conclusion
Central corneal thickness is significantly increased in diabetic patients compared to non-diabetic individuals. Poor glycemic control and longer duration of diabetes are important determinants of increased cct. These findings highlight the need for routine corneal assessment in diabetic patients, as increased cct may influence intraocular pressure measurements and clinical decision-making.
Zitieren
APA
M, K., L, S., & Chandrasekaran, B. (2026). Central Corneal Thickness In Diabetic Vs. Non-Diabetic Eyes: A Cross Sectional Study. International Journal of Drug Delivery Technology, 16(28s). https://doi.org/10.25258/ijddt.16.28s.82
Vancouver
M K, L S, Chandrasekaran B. Central Corneal Thickness In Diabetic Vs. Non-Diabetic Eyes: A Cross Sectional Study. International Journal of Drug Delivery Technology. 2026;16(28s). doi:10.25258/ijddt.16.28s.82
BibTeX
@article{M2026,
author = {M, Kavya and L, Subha and Chandrasekaran, B.},
title = {Central Corneal Thickness In Diabetic Vs. Non-Diabetic Eyes: A Cross Sectional Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {28s},
doi = {10.25258/ijddt.16.28s.82}
}
EUVIMED